Skip to content

A Study of Two Versions of the Uresta Pessary Handle for Women With Stress Urinary Incontinence

A Uresta Bladder Support Handle Comparison Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07706491
Enrollment
113
Registered
2026-07-15
Start date
2026-04-20
Completion date
2026-06-18
Last updated
2026-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress Urinary Incontinence (SUI)

Keywords

stress urinary incontinence, uresta pessary, handle design

Brief summary

The goal of this clinical trial is to learn if a new handle design for the uresta pessary works better than the current handle design for women when they are using the pessary. The main questions it aims to answer are: Is the new pessary equally effective for users. Do pessary users find the new handle design is more or less helpful for insertion and removal of the pessary Is the optional removal string, provided with the new handle, helpful in pessary handling. The participants will use both the original and the new uresta pessary handle designs and complete a questionnaire to rate both handles. The score for the two questionnaires will be compared to determine which handle is best.

Detailed description

1. Introduction This research is a usability comparison study involving the Uresta bladder support, a Class II medical device indicated for adult women experiencing stress urinary incontinence. The device is Food and Drug Administration (FDA)-cleared and licensed for over-the-counter use. The study will compare user experience using the current Uresta handle design and a modified handle design intended to improve the removal process. 2. Study Objective The purpose of this study is to obtain feedback from intended users regarding the efficacy and ease of use and removal characteristics of two versions of the Uresta bladder support handle. The study will also collect feedback on an optional removal string which will be made available to further facilitate removal for certain users. 3. Background Uresta® is a reusable bladder support device designed to reduce urine leakage caused by stress urinary incontinence. When inserted into the vaginal canal, the device supports the urethra and reduces involuntary urine loss during physical activity such as coughing, laughing, or exercising. The efficacy, safety and usability of the use of the uresta pessary for the treatment of bladder leaking has been extensively investigated and the results published1-5 Post-market surveillance has identified potential improvements related to the device. User feedback suggested possible modifications including adding a finger hole to the handle, increasing handle stiffness, and providing an optional removal string to help locate the device during removal.

Interventions

DEVICEpessary handle

the participants will use two pessary handle designs as well as an optional pessary puller string and complete questionnaires to rate their experience

Sponsors

Resilia Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

single cohort, sequential use study

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult women aged 18 years or older * Currently using a Uresta bladder support successfully * Using size 3, 4, or 5 from the Uresta Starter Kit * Living in the United States * Able to participate within 10-20 days of consent * Willing to complete study questionnaires and use the modified device

Exclusion criteria

* Individuals not residing in the United States * Individuals not currently using Uresta * Individuals using sizes other than 3, 4, or 5 * Individuals unable to complete study activities within the study timeline * Pregnant women

Design outcomes

Primary

MeasureTime frameDescription
questionnaireFrom enrolment to completion at 4 weeksA 15 item questionnaire in which each question is anwered on a 5-point likert scale ranging from "strongly disagree"=1 to strongly agree = 5. The higher the score the better the usability and efficacy
Paired samples t-testfrom enrollment to completion at 4 weeksThe scores of each questionnaire will be summed and the mean scores on the pessary handle questionnaires will be compared using a paired samples t-test with a p\<0.05 considered significant

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORScott Farrell, MD

Dalhousie University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 16, 2026